Weijun Zhang

[Fusion expression of Neisseria gonorrhoeae outmembrane protein with a mucosal adjuvant].

Expression, purification, and characterization of recombinant human interleukin 24 in Escherichia coli.

Functional identification of HugZ, a heme oxygenase from Helicobacter pylori.

Cloning a truncated fragment (stx2a(1)) of the shiga-like toxin 2A (1) subunit of EHEC O157:H7: candidate immunogen for a subunit vaccine.

Characterization of enterohemorrhagic Escherichia coli O157:H7 00B015: a Shiga toxin producing but virulence-attenuated isolate.

Fusion expression and immunogenicity of Bordetella pertussis PTS1-FHA protein: implications for the vaccine development.

Identification of a novel linear epitope in tetanus toxin recognized by a protective monoclonal antibody: implications for vaccine design.

Flagella hook protein FlgE is a novel vaccine candidate of Pseudomonas aeruginosa identified by a genomic approach.

A novel self-assembled epitope peptide nanoemulsion vaccine targeting nasal mucosal epithelial cell for reinvigorating CD8 T cell immune activity and inhibiting tumor progression.

Vaccination induces rapid protection against bacterial pneumonia via training alveolar macrophage in mice.

Efficacy, safety, and immunogenicity of an oral recombinant Helicobacter pylori vaccine in children in China: a randomised, double-blind, placebo-controlled, phase 3 trial.

[Recombinant Helicobacter pylori urease B subunit and its biological properties].

LT(K63/R72), a new mutant of Escherichia coli heat-labile enterotoxin, exhibits characteristics more similar to LT(K63) than LT(R72).

Screening and identification of a novel B-cell neutralizing epitope from Helicobacter pylori UreB.

Therapeutic efficacy of a multi-epitope vaccine against Helicobacter pylori infection in BALB/c mice model.

Efficient adenovirus-mediated gene transfer to gastric tissue by oral administration.

Fusion expression and immunogenicity of EHEC EspA-Stx2Al protein: implications for the vaccine development.

Psychological stress enhances the colonization of the stomach by Helicobacter pylori in the BALB/c mouse.

Helicobacter pylori-induced Th17 responses modulate Th1 cell responses, benefit bacterial growth, and contribute to pathology in mice.

Identification of a novel linear epitope on EspA from enterohemorrhagic E. coli using a neutralizing and protective monoclonal antibody.

CD8(+) T cells that produce interleukin-17 regulate myeloid-derived suppressor cells and are associated with survival time of patients with gastric cancer.

miR-30b, down-regulated in gastric cancer, promotes apoptosis and suppresses tumor growth by targeting plasminogen activator inhibitor-1.

Burkholderia pseudomallei survival in lung epithelial cells benefits from miRNA-mediated suppression of ATG10.

Modulation of CD8 memory stem T cell activity and glycogen synthase kinase 3β inhibition enhances anti-tumoral immunity in gastric cancer.

Upexpression of BHLHE40 in gastric epithelial cells increases CXCL12 production through interaction with p-STAT3 in Helicobacter pylori-associated gastritis.

Development of Different Methods for Preparing Outer Membrane Vesicles Vaccine: Impact of Preparation Method on Protective Efficacy.

Extracellular fibrinogen-binding protein released by intracellular Staphylococcus aureus suppresses host immunity by targeting TRAF3.

Respiratory mucosal vaccination of peptide-poloxamine-DNA nanoparticles provides complete protection against lethal SARS-CoV-2 challenge.

Interleukin 17 B regulates colonic myeloid cell infiltration in a mouse model of DSS-induced colitis.

Peptidoglycan-associated lipoprotein contributes to the virulence of Acinetobacter baumannii and serves as a vaccine candidate.

rFSAV promotes Staphylococcus aureus-infected bone defect healing via IL-13- mediated M2 macrophage polarization.

CD39 expression defines exhausted CD4 T cells associated with poor survival and immune evasion in human gastric cancer.

Type VII secretion system extracellular protein B targets STING to evade host anti- immunity.

From Sequence to System: Enhancing IVT mRNA Vaccine Effectiveness through Cutting-Edge Technologies.

mRNA-based platform for preventing and treating by targeted staphylococcal enterotoxin B.